Proteome Sciences plc (LON:PRM) insider Martin Diggle acquired 109,460 shares of Proteome Sciences plc stock in a transaction on Wednesday, October 25th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £3,283.80 ($4,319.08).
Martin Diggle also recently made the following trade(s):
- On Monday, November 6th, Martin Diggle acquired 20,000 shares of Proteome Sciences plc stock. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £600 ($789.16).
- On Wednesday, October 18th, Martin Diggle acquired 256,520 shares of Proteome Sciences plc stock. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £7,695.60 ($10,121.79).
- On Friday, October 20th, Martin Diggle purchased 119,636 shares of Proteome Sciences plc stock. The shares were purchased at an average price of GBX 3 ($0.04) per share, with a total value of £3,589.08 ($4,720.61).
Proteome Sciences plc (LON:PRM) remained flat at $GBX 3.63 ($0.05) during mid-day trading on Friday. The company’s stock had a trading volume of 3,366 shares, compared to its average volume of 274,610. Proteome Sciences plc has a 52-week low of GBX 2.61 ($0.03) and a 52-week high of GBX 6.24 ($0.08).
ILLEGAL ACTIVITY NOTICE: “Proteome Sciences plc (LON:PRM) Insider Purchases £3,283.80 in Stock” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/11/11/proteome-sciences-plc-prm-insider-buys-3283-80-in-stock.html.
Separately, FinnCap reiterated a “corporate” rating and set a GBX 12 ($0.16) price target on shares of Proteome Sciences plc in a research note on Tuesday, July 25th.
Proteome Sciences plc Company Profile
Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications.
Receive News & Ratings for Proteome Sciences plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences plc and related companies with MarketBeat.com's FREE daily email newsletter.